⚕️
Medikal Tanı ve Test Sektörü Hisseleri
Medikal Tanı ve Test Sektörü altında 222 Hisse Senedi
Medikal Tanı ve Test sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$2.4T
Toplam Piyasa Değeri
Medikal Tanı ve Test Sektörü Hisseleri
Sayfa 1/3 (Toplam: 222)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $695.83B | $735.19 | 0.36% |
| ABT | Abbott Laboratories | $228.80B | $131.46 | 0.90% |
| TMO | Thermo Fisher Scientific Inc. | $184.10B | $487.53 | 1.05% |
| BSX | Boston Scientific Corporation | $158.04B | $106.66 | 1.10% |
| DHR | Danaher Corporation | $145.92B | $203.79 | 0.99% |
| MDT | Medtronic plc | $119.58B | $93.33 | 0.56% |
| VRTX | Vertex Pharmaceuticals Incorporated | $102.81B | $401.00 | 2.55% |
| ZTS | Zoetis Inc. | $67.75B | $152.88 | 2.25% |
| REGN | Regeneron Pharmaceuticals, Inc. | $60.20B | $577.90 | 0.48% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $58.59B | $447.00 | 0.11% |
| IDXX | IDEXX Laboratories, Inc. | $51.16B | $639.45 | 1.18% |
| EW | Edwards Lifesciences Corporation | $48.01B | $81.77 | 0.53% |
| GEHC | GE HealthCare Technologies Inc. | $32.69B | $71.60 | 2.89% |
| DXCM | DexCom, Inc. | $29.14B | $74.30 | 1.38% |
| NTRA | Natera, Inc. | $23.24B | $169.34 | 0.65% |
| LH | Laboratory Corporation of America Holdings | $22.75B | $273.78 | 1.51% |
| DGX | Quest Diagnostics Incorporated | $19.98B | $178.70 | 1.62% |
| ILMN | Illumina, Inc. | $15.03B | $97.82 | 2.14% |
| HOLX | Hologic, Inc. | $14.82B | $66.61 | 0.76% |
| MEDP | Medpace Holdings, Inc. | $13.30B | $473.34 | 0.46% |
| TEM | Tempus AI, Inc. | $13.21B | $78.34 | 3.27% |
| SOLV | Solventum Corporation | $12.45B | $71.82 | 1.74% |
| EXEL | Exelixis, Inc. | $10.01B | $37.18 | 0.64% |
| DVA | DaVita Inc. | $9.79B | $136.95 | 0.59% |
| BBIO | BridgeBio Pharma, Inc. | $9.56B | $50.00 | 3.40% |
| IONS | Ionis Pharmaceuticals, Inc. | $9.16B | $57.49 | 34.84% |
| EXAS | Exact Sciences Corporation | $9.09B | $48.01 | 1.24% |
| AVTR | Avantor, Inc. | $9.06B | $13.29 | 1.34% |
| TECH | Bio-Techne Corporation | $8.41B | $53.42 | 2.21% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| GH | Guardant Health, Inc. | $8.29B | $66.51 | 1.35% |
| HSIC | Henry Schein, Inc. | $8.29B | $68.39 | 1.71% |
| BIO | Bio-Rad Laboratories, Inc. | $7.87B | $290.71 | 2.41% |
| RGEN | Repligen Corporation | $6.79B | $120.69 | 1.33% |
| CHE | Chemed Corporation | $6.76B | $464.00 | 1.32% |
| RNA | Avidity Biosciences, Inc. | $6.08B | $47.23 | 1.40% |
| IRTC | iRhythm Technologies, Inc. | $5.50B | $171.08 | 0.65% |
| RDNT | RadNet, Inc. | $5.41B | $70.31 | 2.02% |
| BRKR | Bruker Corporation | $5.04B | $33.23 | 2.21% |
| SHC | Sotera Health Company | $4.59B | $16.16 | 1.28% |
| PTCT | PTC Therapeutics, Inc. | $4.16B | $52.43 | 6.28% |
| ADMA | ADMA Biologics, Inc. | $4.10B | $17.20 | 0.35% |
| LNTH | Lantheus Holdings, Inc. | $3.76B | $55.29 | 0.71% |
| APLS | Apellis Pharmaceuticals, Inc. | $3.56B | $28.17 | 2.18% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $3.55B | $25.68 | 16.57% |
| NVST | Envista Holdings Corp | $3.44B | $20.72 | 2.17% |
| AMED | Amedisys, Inc. | $3.32B | $100.99 | 0.01% |
| SRRK | Scholar Rock Holding Corporation | $3.18B | $33.12 | 1.44% |
| RARE | Ultragenyx Pharmaceutical Inc. | $3.09B | $32.03 | 6.91% |
| CON | Concentra Group Holdings Parent, Inc. | $3.04B | $23.73 | 0.29% |
| KYMR | Kymera Therapeutics, Inc. | $2.91B | $40.69 | 1.24% |
| HAE | Haemonetics Corporation | $2.58B | $53.54 | 1.83% |
| FOLD | Amicus Therapeutics, Inc. | $2.43B | $7.88 | 3.82% |
| DNLI | Denali Therapeutics Inc. | $2.26B | $15.45 | 1.18% |
| IBRX | ImmunityBio, Inc. | $2.25B | $2.38 | 1.71% |
| IDYA | IDEAYA Biosciences, Inc. | $2.23B | $25.48 | 3.79% |
| BLTE | Belite Bio, Inc | $2.12B | $64.90 | 2.97% |
| CGON | CG Oncology, Inc. Common stock | $2.09B | $27.46 | 2.39% |
| PGNY | Progyny, Inc. | $2.01B | $23.41 | 1.10% |
| RXRX | Recursion Pharmaceuticals, Inc. | $1.99B | $4.66 | 0.85% |
| ADPT | Adaptive Biotechnologies Corporation | $1.96B | $12.84 | 2.58% |
| QDEL | QuidelOrtho Corporation | $1.92B | $28.25 | 1.53% |
| ARDT | Ardent Health Partners, LLC | $1.81B | $12.67 | 0.16% |
| CERT | Certara, Inc. | $1.71B | $10.66 | 1.66% |
| TXG | 10x Genomics, Inc. | $1.66B | $13.37 | 4.57% |
| ASTH | Astrana Health, Inc. | $1.59B | $31.88 | 0.25% |
| TWST | Twist Bioscience Corporation | $1.58B | $26.24 | 2.71% |
| MD | Pediatrix Medical Group, Inc. | $1.47B | $16.88 | 1.92% |
| AZTA | Azenta, Inc. | $1.38B | $30.16 | 1.24% |
| TDOC | Teladoc Health, Inc. | $1.35B | $7.64 | 1.16% |
| NVAX | Novavax, Inc. | $1.23B | $7.55 | 1.07% |
| NEOG | Neogen Corporation | $1.23B | $5.64 | 1.91% |
| DVAX | Dynavax Technologies Corporation | $1.16B | $9.91 | 2.08% |
| RCUS | Arcus Biosciences, Inc. | $1.15B | $10.81 | 2.08% |
| GRAL | GRAIL, Inc. | $1.14B | $31.61 | 3.60% |
| OPK | OPKO Health, Inc. | $1.08B | $1.36 | 1.45% |
| NUVB | Nuvation Bio Inc. | $1.01B | $2.95 | 0.67% |
| PRAX | Praxis Precision Medicines, Inc. | $945.80M | $44.94 | 1.32% |
| GERN | Geron Corporation | $937.88M | $1.47 | 5.00% |
| FTRE | Fortrea Holdings Inc. | $908.91M | $10.01 | 1.62% |
| KMTS | Kestra Medical Technologies, Ltd. Common Stock | $827.74M | $16.12 | 0.12% |
| BBNX | Beta Bionics, Inc. | $826.80M | $19.02 | 0.96% |
| IMNM | Immunome, Inc. | $807.78M | $9.28 | 2.42% |
| TNGX | Tango Therapeutics, Inc. | $740.99M | $6.66 | 0.75% |
| CDNA | CareDx, Inc | $737.19M | $13.85 | 1.39% |
| ABUS | Arbutus Biopharma Corporation | $732.29M | $3.82 | 2.96% |
| IKNA | Ikena Oncology, Inc. | $718.82M | $17.16 | 1152.55% |
| GYRE | Gyre Therapeutics, Inc. | $699.76M | $7.71 | 0.39% |
| NRIX | Nurix Therapeutics, Inc. | $696.45M | $9.11 | 2.46% |
| KURA | Kura Oncology, Inc. | $690.04M | $7.95 | 0.63% |
| PROK | ProKidney Corp. | $687.69M | $2.30 | 2.54% |
| FLGT | Fulgent Genetics, Inc. | $682.89M | $22.31 | 0.63% |
| DNA | Ginkgo Bioworks Holdings, Inc. | $652.38M | $11.02 | 13.02% |
| BCAX | Bicara Therapeutics Inc. Common Stock | $649.30M | $11.90 | 0.34% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $644.05M | $2.37 | 2.07% |
| MYGN | Myriad Genetics, Inc. | $642.01M | $6.90 | 8.32% |
| KROS | Keros Therapeutics, Inc. | $638.47M | $15.72 | 3.35% |
| SIGA | SIGA Technologies, Inc. | $617.96M | $8.63 | 2.86% |
| RGLS | Regulus Therapeutics Inc. | $564.95M | $8.16 | 0.00% |
| AVNS | Avanos Medical, Inc. | $554.97M | $11.96 | 0.17% |